Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
657 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02251314 | Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma | completed | — | 12 | University Health Network, TorontoOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT00913536 | Cone Beam Computed Tomography (CT) Bladder | completed | N/A | 30 | University Health Network, TorontoOTHER | 1 | Apr 26, 2019 | clinicaltrials |
| NCT03537911 | Cognitive Support Program for Patients With Brain Metastases | completed | N/A | 18 | University Health Network, TorontoOTHER | 1 | Apr 17, 2019 | clinicaltrials |
| NCT00603915 | A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer | completed | Phase 2 | 20 | University Health Network, TorontoOTHER | 1 | Feb 28, 2019 | clinicaltrials |
| NCT00605566 | Efficacy Study of Sorafenib and Cyclophosphamide to Treat Neuroendocrine Tumors | completed | Phase 2 | 22 | University Health Network, TorontoOTHER | 1 | Feb 19, 2019 | clinicaltrials |
| NCT00045669 | Imatinib Mesylate in Treating Patients With Salivary Gland Cancer | completed | Phase 2 | 16 | University Health Network, TorontoOTHER | 2 | Feb 15, 2019 | clinicaltrials |
| NCT00480090 | A Phase II Study of Ara-C (Cytarabine) in Men With Androgen Independent Prostate Cancer(SLAP) | completed | Phase 2 | 10 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT00483834 | A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer | completed | Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT00610246 | A Study of Radiation With Sorafenib in Advanced Cancer | completed | Phase 1 | 34 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT01083537 | Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction | terminated | Phase 1 / Phase 2 | 1 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT01484860 | Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy | terminated | Phase 2 | 15 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT01543841 | Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood | completed | — | 20 | University Health Network, TorontoOTHER | 1 | Feb 15, 2019 | clinicaltrials |
| NCT02755454 | Perfusion CT Imaging in Lung Cancer With SBRT | completed | N/A | 9 | University Health Network, TorontoOTHER | 1 | Nov 23, 2018 | clinicaltrials |
| NCT02755480 | Ultralow Dose Thoracic Computed Tomography in Immunocompromised Patients(ULDCT-IC) | terminated | N/A | 119 | University Health Network, TorontoOTHER | 1 | Oct 30, 2018 | clinicaltrials |
| NCT03089502 | Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity(CORE) | terminated | N/A | 2 | University Health Network, TorontoOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT00188279 | Minimum Dose Computed Tomography of the Thorax for Follow-up in Patients With Resected Lung Carcinoma | completed | Phase 2 | 311 | University Health Network, TorontoOTHER | 1 | Oct 11, 2018 | clinicaltrials |
| NCT00030576 | Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer | completed | Phase 1 / Phase 2 | 51 | University Health Network, TorontoOTHER | 1 | Oct 10, 2018 | clinicaltrials |
| NCT02489071 | Cognitive Intervention After a Brain Tumor | completed | N/A | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT02818816 | Preoperative Brimonidine on IOP of Patients Undergoing RALP(IOPsTBURG) | completed | Phase 4 | 26 | University Health Network, TorontoOTHER | 1 | Sep 27, 2018 | clinicaltrials |
| NCT02734121 | PEGI to Improve Shared Decision-Making for Breast Reconstruction(PEGI) | completed | N/A | 156 | University Health Network, TorontoOTHER | 1 | Sep 26, 2018 | clinicaltrials |
| NCT00078975 | 3-AP and Gemcitabine in Treating Patients With Recurrent, Unresectable, or Metastatic Pancreatic Cancer | completed | Phase 2 | 26 | University Health Network, TorontoOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT01672736 | A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma | terminated | Phase 1 / Phase 2 | 19 | University Health Network, TorontoOTHER | 2 | Sep 13, 2018 | clinicaltrials |
| NCT01715077 | Study of Ipilimumab in the Immune System | completed | N/A | 4 | University Health Network, TorontoOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00188513 | Intensity Modulated Radiation Therapy - Prostate Cancer | completed | Phase 1 / Phase 2 | 267 | University Health Network, TorontoOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT01062542 | Assessment of Ovarian Reserve in Female Cancer Survivors | completed | — | 210 | University Health Network, TorontoOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT02340611 | A Study of Cediranib and Olaparib at the Time Ovarian Cancer Worsens on Olaparib | completed | Phase 2 | 4 | University Health Network, TorontoOTHER | 1 | Jun 12, 2018 | clinicaltrials |
| NCT02640131 | A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study(BSHR) | completed | N/A | 65 | University Health Network, TorontoOTHER | 1 | Jun 6, 2018 | clinicaltrials |
| NCT03051802 | Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung | terminated | N/A | 1 | University Health Network, TorontoOTHER | 1 | May 24, 2018 | clinicaltrials |
| NCT03349307 | Thin-EBUS in Ex-vivo Human Lungs | completed | N/A | 20 | University Health Network, TorontoOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT01703585 | Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples | completed | — | 45 | University Health Network, TorontoOTHER | 1 | May 9, 2018 | clinicaltrials |
| NCT03356743 | Spectrum Analysis in Ex-vivo Human Lungs | completed | N/A | 20 | University Health Network, TorontoOTHER | 1 | May 4, 2018 | clinicaltrials |
| NCT02043236 | Strategies to Improve Bone Health in Men on ADT | completed | N/A | 159 | University Health Network, TorontoOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT01094665 | MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer(FLTT002) | completed | N/A | 54 | University Health Network, TorontoOTHER | 1 | Mar 9, 2018 | clinicaltrials |
| NCT00756132 | Using Bio Markers to Predict Disease Recurrence and Cognitive Function in High Risk Breast Ca(Cyto-Cog) | completed | — | 120 | University Health Network, TorontoOTHER | 1 | Feb 28, 2018 | clinicaltrials |
| NCT02090660 | Technique for Localization of Pulmonary Nodules Using Spy Thoracoscope System | completed | Phase 2 | 20 | University Health Network, TorontoOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02665078 | Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules | completed | — | 25 | University Health Network, TorontoOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT02794064 | A Prototype Tri-modal Imaging Device for Breast Cancer | completed | Phase 1 | 5 | University Health Network, TorontoOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00462995 | Surgery for Early Lung Cancer With Preoperative Erlotinib (Tarceva): A Clinical Phase II Trial (SELECT)(SELECT) | completed | Phase 2 | 25 | University Health Network, TorontoOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT01972386 | EBUS/Spectrum Analysis | completed | — | 122 | University Health Network, TorontoOTHER | 1 | Feb 23, 2018 | clinicaltrials |
| NCT00004261 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | terminated | Phase 1 | — | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT00743626 | Pap Smear Research Study | completed | N/A | 1,712 | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT02105350 | A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer | withdrawn | Phase 1 | 0 | University Health Network, TorontoOTHER | 0 | Feb 19, 2018 | clinicaltrials |
| NCT02496832 | A Study of Hypoxia Imaging in Advanced Pancreatic Cancer Patients Being Treated With Gemcitabine and TH-302 or TH-302 Placebo | withdrawn | N/A | 0 | University Health Network, TorontoOTHER | 0 | Feb 19, 2018 | clinicaltrials |
| NCT00744549 | Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance | completed | Phase 2 | 16 | University Health Network, TorontoOTHER | 1 | Feb 14, 2018 | clinicaltrials |
| NCT00982059 | Colorectal Cancer Screening for Cancer Survivors | completed | — | 140 | University Health Network, TorontoOTHER | 2 | Jan 31, 2018 | clinicaltrials |
| NCT01270932 | Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure Patients | completed | Phase 2 | 28 | University Health Network, TorontoOTHER | 1 | Dec 29, 2017 | clinicaltrials |
| NCT02993991 | Pre-operative Mocetinostat (MGCD0103) and Durvalumab (MEDI4736) (PRIMED) for Squamous Cell Carcinoma of the Oral Cavity(PRIMED-001) | withdrawn | Phase 1 | 0 | University Health Network, TorontoOTHER | 1 | Dec 29, 2017 | clinicaltrials |
| NCT03359668 | CT Detection of Metastatic Lymphadenopathy in Papillary Thyroid Cancer | completed | N/A | 47 | University Health Network, TorontoOTHER | 0 | Dec 2, 2017 | clinicaltrials |
| NCT00775866 | MRI-Guided Biopsy of Recurrent Prostate Cancer After Radiotherapy | completed | N/A | 82 | University Health Network, TorontoOTHER | 1 | Nov 29, 2017 | clinicaltrials |
| NCT00047229 | Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 27 | University Health Network, TorontoOTHER | 1 | Nov 8, 2017 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials